Aspen’s comparable revenue increases by 12% to R35.4 billion Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a leading pharmaceutical company in the southern hemisphere, has announced positive results for the year ended 30 June 2016 notwithstanding economic pressures and currency weaknesses. Stephen Saad, Aspen Group Chief Executive said, “The positive results… Continue reading Aspen’s comparable revenue increases by 12% to R35.4 billion
